Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, open-label phase III Intergroup study: Effect of adding Bevacizumab to cross over fluoropyrimidine based chemotherapy in patients with mCRC and disease progression under first-line standard CTx/Bevacizumab combination
bevacizumab
ML18147
NCT00700102
malignant neoplasm of colon/rectum
Phase 3
 
January 2014

Powered by ideaPoint, Inc.